메뉴 건너뛰기




Volumn 16, Issue 8, 2015, Pages 16833-16847

The miR-200 family: Versatile players in epithelial ovarian cancer

Author keywords

Chemoresistance; Expression; Metastasis; miR 200 family; Ovarian carcinoma

Indexed keywords

MICRORNA 200; PACLITAXEL; RNA INDUCED SILENCING COMPLEX; ANTINEOPLASTIC AGENT; MICRORNA;

EID: 84937862263     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160816833     Document Type: Review
Times cited : (66)

References (100)
  • 1
    • 0027751663 scopus 로고
    • The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
    • Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75, 843–854.
    • (1993) Cell , vol.75 , pp. 843-854
    • Lee, R.C.1    Feinbaum, R.L.2    Ambros, V.3
  • 2
    • 0027730383 scopus 로고
    • Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C
    • Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75, 855–862.
    • (1993) Elegans. Cell , vol.75 , pp. 855-862
    • Wightman, B.1    Ha, I.2    Ruvkun, G.3
  • 3
    • 84891818318 scopus 로고    scopus 로고
    • MiRBase: Annotating high confidence microRNAs using deep sequencing data
    • Kozomara, A.; Griffiths-Jones, S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014, 42, D68–73.
    • (2014) Nucleic Acids Res , vol.42 , pp. 68-73
    • Kozomara, A.1    Griffiths-Jones, S.2
  • 5
    • 58249088751 scopus 로고    scopus 로고
    • MicroRNAs: Target recognition and regulatory functions
    • Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233
    • (2009) Cell , vol.136 , pp. 215-233
    • Bartel, D.P.1
  • 7
    • 84875992976 scopus 로고    scopus 로고
    • Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation
    • Hausser, J.; Syed, A.P.; Bilen, B.; Zavolan, M. Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res. 2013, 23, 604–615.
    • (2013) Genome Res , vol.23 , pp. 604-615
    • Hausser, J.1    Syed, A.P.2    Bilen, B.3    Zavolan, M.4
  • 8
    • 3042767202 scopus 로고    scopus 로고
    • MicroRNAs: Small RNAs with a big role in gene regulation
    • He, L.; Hannon, G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5, 522–531.
    • (2004) Nat. Rev. Genet , vol.5 , pp. 522-531
    • He, L.1    Hannon, G.J.2
  • 9
    • 0347444723 scopus 로고    scopus 로고
    • MicroRNAs: Genomics, biogenesis, mechanism, and function
    • Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281–297.
    • (2004) Cell , vol.116 , pp. 281-297
    • Bartel, D.P.1
  • 10
    • 70349320158 scopus 로고    scopus 로고
    • Causes and consequences of microRNA dysregulation in cancer
    • Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10, 704–714.
    • (2009) Nat. Rev. Genet , vol.10 , pp. 704-714
    • Croce, C.M.1
  • 12
    • 65349117527 scopus 로고    scopus 로고
    • MiRNAs and cancer
    • Visone, R.; Croce, C.M. MiRNAs and cancer. Am. J. Pathol. 2009, 174, 1131–1138.
    • (2009) Am. J. Pathol , vol.174 , pp. 1131-1138
    • Visone, R.1    Croce, C.M.2
  • 13
    • 84924962270 scopus 로고    scopus 로고
    • Dysregulation of microRNA biogenesis and gene silencing in cancer
    • Hata, A.; Lieberman, J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci. Signal. 2015, 8, re3.
    • (2015) Sci. Signal , vol.8
    • Hata, A.1    Lieberman, J.2
  • 14
    • 33750370444 scopus 로고    scopus 로고
    • MicroRNA signatures in human cancers
    • Calin, G.A.; Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857–866.
    • (2006) Nat. Rev. Cancer , vol.6 , pp. 857-866
    • Calin, G.A.1    Croce, C.M.2
  • 15
    • 33645294070 scopus 로고    scopus 로고
    • Oncomirs—MicroRNAs with a role in cancer
    • Esquela-Kerscher, A.; Slack, F.J. Oncomirs—MicroRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6, 259–269.
    • (2006) Nat. Rev. Cancer , vol.6 , pp. 259-269
    • Esquela-Kerscher, A.1    Slack, F.J.2
  • 16
    • 79952809713 scopus 로고    scopus 로고
    • The emerging role of microRNAs in drug responses
    • Zhang, W.; Dolan, M.E. The emerging role of microRNAs in drug responses. Curr. Opin. Mol. Ther. 2010, 12, 695–702.
    • (2010) Curr. Opin. Mol. Ther , vol.12 , pp. 695-702
    • Zhang, W.1    Dolan, M.E.2
  • 17
    • 79955649353 scopus 로고    scopus 로고
    • Cancer microRNAs: From subtype profiling to predictors of response to therapy
    • Chan, E.; Prado, D.E.; Weidhaas, J.B. Cancer microRNAs: From subtype profiling to predictors of response to therapy. Trends Mol. Med. 2011, 17, 235–243.
    • (2011) Trends Mol. Med , vol.17 , pp. 235-243
    • Chan, E.1    Prado, D.E.2    Weidhaas, J.B.3
  • 18
    • 79956069781 scopus 로고    scopus 로고
    • Searching for the “melano-miRs”: MiR-214 drives melanoma metastasis
    • Bar-Eli, M. Searching for the “melano-miRs”: miR-214 drives melanoma metastasis. EMBO J. 2011, 30, 1880–1881.
    • (2011) EMBO J , vol.30 , pp. 1880-1881
    • Bar-Eli, M.1
  • 21
    • 84860577261 scopus 로고    scopus 로고
    • Circulating microRNAs as noninvasive biomarkers in breast cancer
    • Cortez, M.A.; Welsh, J.W.; Calin, G.A. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res. 2012, 195, 151–161.
    • (2012) Recent Results Cancer Res , vol.195 , pp. 151-161
    • Cortez, M.A.1    Welsh, J.W.2    Calin, G.A.3
  • 22
    • 84887101163 scopus 로고    scopus 로고
    • MicroRNAs and other non-coding RNAs as targets for anticancer drug development
    • Ling, H.; Fabbri, M.; Calin, G.A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug. Discov. 2013, 12, 847–865.
    • (2013) Nat. Rev. Drug. Discov , vol.12 , pp. 847-865
    • Ling, H.1    Fabbri, M.2    Calin, G.A.3
  • 23
    • 84905122848 scopus 로고    scopus 로고
    • MicroRNAs in cancer: Biomarkers, functions and therapy
    • Hayes, J.; Peruzzi, P.P.; Lawler, S. MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol. Med. 2014, 20, 460–469.
    • (2014) Trends Mol. Med , vol.20 , pp. 460-469
    • Hayes, J.1    Peruzzi, P.P.2    Lawler, S.3
  • 24
    • 84902533403 scopus 로고    scopus 로고
    • MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip
    • Shah, M.Y.; Calin, G.A. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip. Rev. RNA 2014, 5, 537–548.
    • (2014) Rev. RNA , vol.5 , pp. 537-548
    • Shah, M.Y.1    Calin, G.A.2
  • 26
    • 84867334962 scopus 로고    scopus 로고
    • Cell-to-cell miRNA transfer: From body homeostasis to therapy
    • Redis, R.S.; Calin, S.; Yang, Y.; You, M.J.; Calin, G.A. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol. Ther. 2012, 136, 169–174.
    • (2012) Pharmacol. Ther , vol.136 , pp. 169-174
    • Redis, R.S.1    Calin, S.2    Yang, Y.3    You, M.J.4    Calin, G.A.5
  • 27
    • 84948571622 scopus 로고    scopus 로고
    • MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment
    • Kohlhapp, F.J.; Mitra, A.K.; Lengyel, E.; Peter, M.E. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene 2015, doi:10.1038/onc.2015.89.
    • (2015) Oncogene
    • Kohlhapp, F.J.1    Mitra, A.K.2    Lengyel, E.3    Peter, M.E.4
  • 30
    • 84887160644 scopus 로고    scopus 로고
    • The role of microRNAs in the tumorigenesis of ovarian cancer
    • Di Leva, G.; Croce, C.M. The role of microRNAs in the tumorigenesis of ovarian cancer. Front. Oncol. 2013, 3, 153.
    • (2013) Front. Oncol , vol.3 , pp. 153
    • Di Leva, G.1    Croce, C.M.2
  • 31
    • 84904612549 scopus 로고    scopus 로고
    • Regulation of metastasis by microRNAs in ovarian cancer
    • Wang, Y.; Kim, S.; Kim, I.M. Regulation of metastasis by microRNAs in ovarian cancer. Front. Oncol. 2014, 4, 143.
    • (2014) Front. Oncol , vol.4 , pp. 143
    • Wang, Y.1    Kim, S.2    Kim, I.M.3
  • 34
    • 67649440886 scopus 로고    scopus 로고
    • The biology of ovarian cancer: New opportunities for translation. Nat
    • Bast, R.C.; Hennessy, B.; Mills, G.B. The biology of ovarian cancer: New opportunities for translation. Nat. Rev. Cancer 2009, 9, 415–428.
    • (2009) Rev. Cancer , vol.9 , pp. 415-428
    • Bast, R.C.1    Hennessy, B.2    Mills, G.B.3
  • 36
    • 70349222742 scopus 로고    scopus 로고
    • Ovarian cancer: An overview
    • Roett, M.A.; Evans, P. Ovarian cancer: An overview. Am. Fam. Physician 2009, 80, 609–616.
    • (2009) Am. Fam. Physician , vol.80 , pp. 609-616
    • Roett, M.A.1    Evans, P.2
  • 40
    • 84873582060 scopus 로고    scopus 로고
    • Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
    • Yang, D.; Sun, Y.; Hu, L.; Zheng, H.; Ji, P.; Pecot, C.V.; Zhao, Y.; Reynolds, S.; Cheng, H.; Rupaimoole, R.; et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 2013, 23, 186–199.
    • (2013) Cancer Cell , vol.23 , pp. 186-199
    • Yang, D.1    Sun, Y.2    Hu, L.3    Zheng, H.4    Ji, P.5    Pecot, C.V.6    Zhao, Y.7    Reynolds, S.8    Cheng, H.9    Rupaimoole, R.10
  • 41
    • 84927130979 scopus 로고    scopus 로고
    • The microRNA-200 family: Small molecules with novel roles in cancer development, progression and therapy
    • Humphries, B.; Yang, C. The microRNA-200 family: Small molecules with novel roles in cancer development, progression and therapy. Oncotarget 2015, 6, 6472–6498.
    • (2015) Oncotarget , vol.6 , pp. 6472-6498
    • Humphries, B.1    Yang, C.2
  • 42
    • 84926676589 scopus 로고    scopus 로고
    • The regulatory role of microRNAs in EMT and cancer
    • 2015
    • Zaravinos, A. The regulatory role of microRNAs in EMT and cancer. J. Oncol. 2015, 2015, 865-816.
    • (2015) J. Oncol , pp. 816-865
    • Zaravinos, A.1
  • 43
    • 84897872316 scopus 로고    scopus 로고
    • Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research. Gynecol
    • Gadducci, A.; Sergiampietri, C.; Lanfredini, N.; Guiggi, I. Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research. Gynecol. Endocrinol. 2014, 30, 266–271.
    • (2014) Endocrinol , vol.30 , pp. 266-271
    • Gadducci, A.1    Sergiampietri, C.2    Lanfredini, N.3    Guiggi, I.4
  • 45
    • 39049086391 scopus 로고    scopus 로고
    • MicroRNA expression profiling in human ovarian cancer: MiR-214 induces cell survival and cisplatin resistance by targeting PTEN
    • Yang, H.; Kong, W.; He, L.; Zhao, J.J.; O’Donnell, J.D.; Wang, J.; Wenham, R.M.; Coppola, D.; Kruk, P.A.; Nicosia, S.V, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008, 68, 425–433.
    • (2008) Cancer Res , vol.68 , pp. 425-433
    • Yang, H.1    Kong, W.2    He, L.3    Zhao, J.J.4    O’Donnell, J.D.5    Wang, J.6    Wenham, R.M.7    Coppola, D.8    Kruk, P.A.9    Nicosia, S.V.10
  • 50
    • 84886802501 scopus 로고    scopus 로고
    • The role of the fallopian tube in the origin of ovarian cancer
    • Erickson, B.K.; Conner, M.G.; Landen, C.N. The role of the fallopian tube in the origin of ovarian cancer. Am. J. Obstet. Gynecol. 2013, 209, 409–414.
    • (2013) Am. J. Obstet. Gynecol , vol.209 , pp. 409-414
    • Erickson, B.K.1    Conner, M.G.2    Landen, C.N.3
  • 51
    • 84886285788 scopus 로고    scopus 로고
    • Coming into focus: The nonovarian origins of ovarian cancer
    • Dubeau, L.; Drapkin, R. Coming into focus: The nonovarian origins of ovarian cancer. Ann. Oncol. 2013, 24, 828–835.
    • (2013) Ann. Oncol , vol.24 , pp. 828-835
    • Dubeau, L.1    Drapkin, R.2
  • 53
    • 84879112411 scopus 로고    scopus 로고
    • Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis? Gynecol
    • Auersperg, N. Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis? Gynecol. Oncol. 2013, 130, 246–251.
    • (2013) Oncol , vol.130 , pp. 246-251
    • Auersperg, N.1
  • 54
    • 0142188162 scopus 로고    scopus 로고
    • Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies
    • Zorn, K.K.; Jazaeri, A.A.; Awtrey, C.S.; Gardner, G.J.; Mok, S.C.; Boyd, J.; Birrer, M.J. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin. Cancer Res. 2003, 9, 4811–4818.
    • (2003) Clin. Cancer Res , vol.9 , pp. 4811-4818
    • Zorn, K.K.1    Jazaeri, A.A.2    Awtrey, C.S.3    Gardner, G.J.4    Mok, S.C.5    Boyd, J.6    Birrer, M.J.7
  • 56
    • 34249302620 scopus 로고    scopus 로고
    • Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat
    • Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659.
    • (2007) Cell Biol , vol.9 , pp. 654-659
    • Valadi, H.1    Ekström, K.2    Bossios, A.3    Sjöstrand, M.4    Lee, J.J.5    Lötvall, J.O.6
  • 57
    • 84859927971 scopus 로고    scopus 로고
    • Tumor cell-derived exosomes: A message in a bottle. Biochim. Biophys
    • Kharaziha, P.; Ceder, S.; Li, Q.; Panaretakis, T. Tumor cell-derived exosomes: A message in a bottle. Biochim. Biophys. Acta 2012, 1826, 103–111.
    • (2012) Acta , vol.1826 , pp. 103-111
    • Kharaziha, P.1    Ceder, S.2    Li, Q.3    Panaretakis, T.4
  • 58
    • 45449093192 scopus 로고    scopus 로고
    • MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol
    • Taylor, D.D.; Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110, 13–21.
    • (2008) Oncol , vol.110 , pp. 13-21
    • Taylor, D.D.1    Gercel-Taylor, C.2
  • 59
    • 84872353766 scopus 로고    scopus 로고
    • Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
    • Kan, C.W.; Hahn, M.A.; Gard, G.B.; Maidens, J.; Huh, J.Y.; Marsh, D.J.; Howell, V.M. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer 2012, 12, 627.
    • (2012) BMC Cancer , vol.12 , pp. 627
    • Kan, C.W.1    Hahn, M.A.2    Gard, G.B.3    Maidens, J.4    Huh, J.Y.5    Marsh, D.J.6    Howell, V.M.7
  • 60
    • 77955172153 scopus 로고    scopus 로고
    • MiR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
    • Uhlmann, S.; Zhang, J.D.; Schwäger, A.; Mannsperger, H.; Riazalhosseini, Y.; Burmester, S.; Ward, A.; Korf, U.; Wiemann, S.; Sahin, O. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 2010, 29, 4297–4306.
    • (2010) Oncogene , vol.29 , pp. 4297-4306
    • Uhlmann, S.1    Zhang, J.D.2    Schwäger, A.3    Mannsperger, H.4    Riazalhosseini, Y.5    Burmester, S.6    Ward, A.7    Korf, U.8    Wiemann, S.9    Sahin, O.10
  • 62
    • 34548565806 scopus 로고    scopus 로고
    • Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
    • Hurteau, G.J.; Carlson, J.A.; Spivack, S.D.; Brock, G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007, 67, 7972–7976.
    • (2007) Cancer Res , vol.67 , pp. 7972-7976
    • Hurteau, G.J.1    Carlson, J.A.2    Spivack, S.D.3    Brock, G.J.4
  • 64
    • 41649091906 scopus 로고    scopus 로고
    • The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
    • Park, S.M.; Gaur, A.B.; Lengyel, E.; Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22, 894–907.
    • (2008) Genes Dev , vol.22 , pp. 894-907
    • Park, S.M.1    Gaur, A.B.2    Lengyel, E.3    Peter, M.E.4
  • 65
    • 47249091921 scopus 로고    scopus 로고
    • The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
    • Korpal, M.; Lee, E.S.; Hu, G.; Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283, 14910–14914.
    • (2008) J. Biol. Chem , vol.283 , pp. 14910-14914
    • Korpal, M.1    Lee, E.S.2    Hu, G.3    Kang, Y.4
  • 69
    • 35548974844 scopus 로고    scopus 로고
    • The transcription factor ZEB1 (DeltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
    • Aigner, K.; Dampier, B.; Descovich, L.; Mikula, M.; Sultan, A.; Schreiber, M.; Mikulits, W.; Brabletz, T.; Strand, D.; Obrist, P, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007, 26, 6979–6988.
    • (2007) Oncogene , vol.26 , pp. 6979-6988
    • Aigner, K.1    Dampier, B.2    Descovich, L.3    Mikula, M.4    Sultan, A.5    Schreiber, M.6    Mikulits, W.7    Brabletz, T.8    Strand, D.9    Obrist, P.10
  • 71
    • 85011936092 scopus 로고    scopus 로고
    • The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis
    • Korpal, M.; Kang, Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2008, 5, 115–119.
    • (2008) RNA Biol , vol.5 , pp. 115-119
    • Korpal, M.1    Kang, Y.2
  • 72
    • 54049089608 scopus 로고    scopus 로고
    • MicroRNAs as regulators of epithelial-mesenchymal transition
    • Gregory, P.A.; Bracken, C.P.; Bert, A.G.; Goodall, G.J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7, 3112–3118.
    • (2008) Cell Cycle , vol.7 , pp. 3112-3118
    • Gregory, P.A.1    Bracken, C.P.2    Bert, A.G.3    Goodall, G.J.4
  • 73
    • 44649163918 scopus 로고    scopus 로고
    • A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
    • Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9, 582–589.
    • (2008) EMBO Rep , vol.9 , pp. 582-589
    • Burk, U.1    Schubert, J.2    Wellner, U.3    Schmalhofer, O.4    Vincan, E.5    Spaderna, S.6    Brabletz, T.7
  • 74
    • 54049084380 scopus 로고    scopus 로고
    • A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
    • Bracken, C.P.; Gregory, P.A.; Kolesnikoff, N.; Bert, A.G.; Wang, J.; Shannon, M.F.; Goodall, G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68, 7846–7854.
    • (2008) Cancer Res , vol.68 , pp. 7846-7854
    • Bracken, C.P.1    Gregory, P.A.2    Kolesnikoff, N.3    Bert, A.G.4    Wang, J.5    Shannon, M.F.6    Goodall, G.J.7
  • 75
    • 77956230322 scopus 로고    scopus 로고
    • The ZEB/miR-200 feedback loop—A motor of cellular plasticity in development and cancer?
    • Brabletz, S.; Brabletz, T. The ZEB/miR-200 feedback loop—A motor of cellular plasticity in development and cancer? EMBO Rep. 2010, 11, 670–677.
    • (2010) EMBO Rep , vol.11 , pp. 670-677
    • Brabletz, S.1    Brabletz, T.2
  • 76
    • 84892588866 scopus 로고    scopus 로고
    • Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells
    • Jabbari, N.; Reavis, A.N.; McDonald, J.F. Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells. J. Ovarian Res. 2014, 7, 12.
    • (2014) J. Ovarian Res , vol.7 , pp. 12
    • Jabbari, N.1    Reavis, A.N.2    McDonald, J.F.3
  • 77
    • 84905652883 scopus 로고    scopus 로고
    • Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells. Mol
    • Sugiyama, K.; Kajiyama, H.; Shibata, K.; Yuan, H.; Kikkawa, F.; Senga, T. Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells. Mol. Cancer Ther. 2014, 13, 2081–2091.
    • (2014) Cancer Ther , vol.13 , pp. 2081-2091
    • Sugiyama, K.1    Kajiyama, H.2    Shibata, K.3    Yuan, H.4    Kikkawa, F.5    Senga, T.6
  • 79
    • 84870922071 scopus 로고    scopus 로고
    • Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
    • Zaman, M.S.; Maher, D.M.; Khan, S.; Jaggi, M.; Chauhan, S.C. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. J. Ovarian Res. 2012, 5, 44.
    • (2012) J. Ovarian Res , vol.5 , pp. 44
    • Zaman, M.S.1    Maher, D.M.2    Khan, S.3    Jaggi, M.4    Chauhan, S.C.5
  • 80
    • 84955210013 scopus 로고    scopus 로고
    • Achieving successful delivery of oligonucleotides—From physico-chemical characterization to in vivo evaluation
    • Scomparin, A.; Polyak, D.; Krivitsky, A.; Satchi-Fainaro, R. Achieving successful delivery of oligonucleotides—From physico-chemical characterization to in vivo evaluation. Biotechnol. Adv. 2015, doi:10.1016/j.biotechadv.2015.04.008.
    • (2015) Biotechnol. Adv
    • Scomparin, A.1    Polyak, D.2    Krivitsky, A.3    Satchi-Fainaro, R.4
  • 81
    • 84905503012 scopus 로고    scopus 로고
    • Therapeutic targeting of microRNAs: Current status and future challenges. Nat
    • Li, Z.; Rana, T.M. Therapeutic targeting of microRNAs: Current status and future challenges. Nat. Rev. Drug Discov. 2014, 13, 622–638.
    • (2014) Rev. Drug Discov , vol.13 , pp. 622-638
    • Li, Z.1    Rana, T.M.2
  • 82
    • 84904763687 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
    • Koutsaki, M.; Spandidos, D.A.; Zaravinos, A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 2014, 351, 173–181.
    • (2014) Cancer Lett , vol.351 , pp. 173-181
    • Koutsaki, M.1    Spandidos, D.A.2    Zaravinos, A.3
  • 83
    • 19944430079 scopus 로고    scopus 로고
    • Ferrandina, G.; et al. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin
    • Mozzetti, S.; Ferlini, C.; Concolino, P.; Filippetti, F.; Raspaglio, G.; Prislei, S.; Gallo, D.; Martinelli, E.; Ranelletti, F.O.; Ferrandina, G.; et al. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin. Cancer Res. 2005, 11, 298–305.
    • (2005) Cancer Res , vol.11 , pp. 298-305
    • Mozzetti, S.1    Ferlini, C.2    Concolino, P.3    Filippetti, F.4    Raspaglio, G.5    Prislei, S.6    Gallo, D.7    Martinelli, E.8    Ranelletti, F.O.9
  • 84
    • 44449148739 scopus 로고    scopus 로고
    • Potential mechanisms of resistance to microtubule inhibitors
    • Kavallaris, M.; Annereau, J.P.; Barret, J.M. Potential mechanisms of resistance to microtubule inhibitors. Semin. Oncol. 2008, 35, S22–S27.
    • (2008) Semin. Oncol , vol.35
    • Kavallaris, M.1    Annereau, J.P.2    Barret, J.M.3
  • 85
    • 41349121211 scopus 로고    scopus 로고
    • Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III β-tubulin
    • Umezu, T.; Shibata, K.; Kajiyama, H.; Terauchi, M.; Ino, K.; Nawa, A.; Kikkawa, F. Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III β-tubulin. Int. J. Gynecol. Pathol. 2008, 27, 207–212.
    • (2008) Int. J. Gynecol. Pathol , vol.27 , pp. 207-212
    • Umezu, T.1    Shibata, K.2    Kajiyama, H.3    Terauchi, M.4    Ino, K.5    Nawa, A.6    Kikkawa, F.7
  • 86
    • 66849140943 scopus 로고    scopus 로고
    • MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
    • Cochrane, D.R.; Spoelstra, N.S.; Howe, E.N.; Nordeen, S.K.; Richer, J.K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol. Cancer Ther. 2009, 8, 1055–1066.
    • (2009) Mol. Cancer Ther , vol.8 , pp. 1055-1066
    • Cochrane, D.R.1    Spoelstra, N.S.2    Howe, E.N.3    Nordeen, S.K.4    Richer, J.K.5
  • 87
    • 77954863985 scopus 로고    scopus 로고
    • Loss of miR-200c: A marker of aggressiveness and chemoresistance in female reproductive Cancers
    • Cochrane, D.R.; Howe, E.N.; Spoelstra, N.S.; Richer, J.K. Loss of miR-200c: A marker of aggressiveness and chemoresistance in female reproductive Cancers. J. Oncol. 2010, 2010, 821-717.
    • (2010) J. Oncol , pp. 171-821
    • Cochrane, D.R.1    Howe, E.N.2    Spoelstra, N.S.3    Richer, J.K.4
  • 89
    • 79952041791 scopus 로고    scopus 로고
    • Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: A retrospective study of two independent tumour tissue collections
    • Marchini, S.; Cavalieri, D.; Fruscio, R.; Calura, E.; Garavaglia, D.; Fuso Nerini, I.; Mangioni, C.; Cattoretti, G.; Clivio, L.; Beltrame, L, et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: A retrospective study of two independent tumour tissue collections. Lancet Oncol. 2011, 12, 273–285.
    • (2011) Lancet Oncol , vol.12 , pp. 273-285
    • Marchini, S.1    Cavalieri, D.2    Fruscio, R.3    Calura, E.4    Garavaglia, D.5    Fuso Nerini, I.6    Mangioni, C.7    Cattoretti, G.8    Clivio, L.9    Beltrame, L.10
  • 92
    • 84902471555 scopus 로고    scopus 로고
    • Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer
    • Cao, Q.; Lu, K.; Dai, S.; Hu, Y.; Fan, W. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Int. J. Clin. Exp. Pathol. 2014, 7, 2392–2401.
    • (2014) Int. J. Clin. Exp. Pathol , vol.7 , pp. 2392-2401
    • Cao, Q.1    Lu, K.2    Dai, S.3    Hu, Y.4    Fan, W.5
  • 94
    • 24944486664 scopus 로고    scopus 로고
    • Resistance to paclitaxel is proportional to cellular total antioxidant capacity
    • Ramanathan, B.; Jan, K.Y.; Chen, C.H.; Hour, T.C.; Yu, H.J.; Pu, Y.S. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 2005, 65, 8455–8460
    • (2005) Cancer Res , vol.65 , pp. 8455-8460
    • Ramanathan, B.1    Jan, K.Y.2    Chen, C.H.3    Hour, T.C.4    Yu, H.J.5    Pu, Y.S.6
  • 95
    • 34248582844 scopus 로고    scopus 로고
    • Novel action of paclitaxel against cancer cells: Bystander effect mediated by reactive oxygen species
    • Alexandre, J.; Hu, Y.; Lu, W.; Pelicano, H.; Huang, P. Novel action of paclitaxel against cancer cells: Bystander effect mediated by reactive oxygen species. Cancer Res. 2007, 67, 3512–3517.
    • (2007) Cancer Res , vol.67 , pp. 3512-3517
    • Alexandre, J.1    Hu, Y.2    Lu, W.3    Pelicano, H.4    Huang, P.5
  • 99
    • 84893697547 scopus 로고    scopus 로고
    • Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
    • Vilming Elgaaen, B.; Olstad, O.K.; Haug, K.B.; Brusletto, B.; Sandvik, L.; Staff, A.C.; Gautvik, K.M.; Davidson, B. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. BMC Cancer 2014, 14, 80.
    • (2014) BMC Cancer , vol.14 , pp. 80
    • Vilming Elgaaen, B.1    Olstad, O.K.2    Haug, K.B.3    Brusletto, B.4    Sandvik, L.5    Staff, A.C.6    Gautvik, K.M.7    Davidson, B.8
  • 100
    • 84938961681 scopus 로고    scopus 로고
    • MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
    • Gao, Y.C.; Wu, J. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Tumour Biol. 2015, doi: 10.1007/s13277-015-3138-3.
    • (2015) Tumour Biol
    • Gao, Y.C.1    Wu, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.